$FXE
Invesco CurrencyShares Euro Trust Stock $fxe

$fxe Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000095017024122597 Filed on November 07, 2024

Income Statement

Concept	2024 Q3
Revenue	$1.118M
YoY Change	-23.36%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$178.2K
YoY Change	-26.03%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	$940.1K
YoY Change	-22.83%
Net Earnings / Revenue	84.06%
Basic Earnings Per Share	$0.54
Diluted Earnings Per Share	$0.54
COMMON SHARES
Basic Shares Outstanding	1.747M
Diluted Shares Outstanding	1.747M

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$190.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$190.9M
YoY Change	-17.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$60.55K
YoY Change	-33.76%
SHAREHOLDERS EQUITY
Retained Earnings	$0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity	$190.9M
YoY Change	-17.03%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	$940.1K
YoY Change	-22.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$946.5K
YoY Change	-19.64%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2005-12-05
CY2024Q3	fxe	Initial Incorporation Deposit With Bank Sponsor InitialIncorporationDepositWithBankSponsor	100
	fxe	Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit	2
	fxe	Stock Redeemable In Baskets Number Of Shares StockRedeemableInBasketsNumberOfShares	50000
	us-gaap	Use Of Estimates UseOfEstimates	<div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:1.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:1.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">B.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounting Estimates</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001328598
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Registrant Name EntityRegistrantName	Invesco CurrencyShares Euro Trust
CY2024Q3	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4	us-gaap	Other Liability Current Related Party Type Extensible Enumeration OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2024Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare
CY2023Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32694
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-3613421
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3500 Lacey Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 700
	dei	Entity Address City Or Town EntityAddressCityOrTown	Downers Grove
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60515
	dei	City Area Code CityAreaCode	800
	dei	Local Phone Number LocalPhoneNumber	983-0903
	dei	Security12b Title Security12bTitle	Common Units of Beneficial Interest
	dei	Trading Symbol TradingSymbol	FXE
	dei	Security Exchange Name SecurityExchangeName	NYSEArca
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1850000
CY2024Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	190494276
CY2023Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	214030570
CY2024Q3	fxe	Non Interest Bearing Deposits In Banks NonInterestBearingDepositsInBanks	10284
CY2024Q3	fxe	Subscriptions Receivable SubscriptionsReceivable	0
CY2023Q4	fxe	Subscriptions Receivable SubscriptionsReceivable	5095966
CY2024Q3	us-gaap	Due From Banks DueFromBanks	0
CY2023Q4	us-gaap	Due From Banks DueFromBanks	154445
CY2024Q3	us-gaap	Interest Receivable Current InterestReceivableCurrent	370849
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	505646
CY2024Q3	us-gaap	Assets Assets	190875409
CY2023Q4	us-gaap	Assets Assets	219786627
CY2024Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	0
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	152031
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60547
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	73957
CY2024Q3	us-gaap	Liabilities Liabilities	60547
CY2023Q4	us-gaap	Liabilities Liabilities	225988
CY2024Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	1850000
CY2024Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	1850000
CY2024Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.54
CY2023Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.5
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	1.73
CY2023Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2150000
CY2023Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2150000
CY2024Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	190814862
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	219560639
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	190875409
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	219786627
CY2024Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1118359
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1459197
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3803847
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3760579
CY2024Q3	us-gaap	Revenues Revenues	1118359
CY2023Q3	us-gaap	Revenues Revenues	1459197
	us-gaap	Revenues Revenues	3803847
	us-gaap	Revenues Revenues	3760579
CY2024Q3	us-gaap	Sponsor Fees SponsorFees	178242
CY2023Q3	us-gaap	Sponsor Fees SponsorFees	240957
	us-gaap	Sponsor Fees SponsorFees	572902
	us-gaap	Sponsor Fees SponsorFees	809239
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	178242
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	240957
	us-gaap	Operating Expenses OperatingExpenses	572902
	us-gaap	Operating Expenses OperatingExpenses	809239
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	940117
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1218240
	us-gaap	Net Income Loss NetIncomeLoss	3230945
	us-gaap	Net Income Loss NetIncomeLoss	2951340
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.51
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.7
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.7
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.1
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.1
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1747283
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1747283
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2370652
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2370652
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1896898
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1896898
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2694322
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2694322
CY2024Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	946519
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	940117
CY2024Q3	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	6402
CY2023Q3	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1177819
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1218240
CY2023Q3	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-40421
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3276798
	us-gaap	Net Income Loss NetIncomeLoss	3230945
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	45853
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2548491
	us-gaap	Net Income Loss NetIncomeLoss	2951340
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	-402849
	us-gaap	Net Income Loss NetIncomeLoss	3230945
	us-gaap	Net Income Loss NetIncomeLoss	2951340
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-134797
	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	332867
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-13410
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-33143
	fxe	Increase Decrease In Cash Due From Depository IncreaseDecreaseInCashDueFromDepository	-154445
	fxe	Increase Decrease In Cash Due From Depository IncreaseDecreaseInCashDueFromDepository	-0
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3506777
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2585330
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	3276798
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	2548491
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	80476324
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	124870310
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	104814993
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	179877697
	fxe	Increase Decrease In Payable For Euro Dollar Deposits Overdrawn IncreaseDecreaseInPayableForEuroDollarDepositsOverdrawn	-152031
	fxe	Increase Decrease In Payable For Euro Dollar Deposits Overdrawn IncreaseDecreaseInPayableForEuroDollarDepositsOverdrawn	5872
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-27767498
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57550006
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	724427
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1034836
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23536294
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55999512
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	214030570
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	285555944
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	190494276
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	229556432
	us-gaap	Interest Paid Net InterestPaidNet	0
	us-gaap	Interest Paid Net InterestPaidNet	0
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.95
CY2024Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	946519
CY2023Q3	us-gaap	Payments Of Dividends PaymentsOfDividends	1177819
	us-gaap	Payments Of Dividends PaymentsOfDividends	3276798
	us-gaap	Payments Of Dividends PaymentsOfDividends	2548491
CY2024Q3	us-gaap	Partners Capital Distribution Amount Per Share PartnersCapitalDistributionAmountPerShare	0.17264
CY2024Q2	us-gaap	Distributed Earnings DistributedEarnings	319384
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
	fxe	Minimum Period Required To Stay For Tax Liability MinimumPeriodRequiredToStayForTaxLiability	P183D
CY2024Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	0.023
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	69197826
	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	96877633
CY2024Q3	us-gaap	Cash Cash	170684868
CY2024Q3	us-gaap	Cash Cash	190494276
CY2023	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	143007863
CY2023	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	212205189
CY2023Q4	us-gaap	Cash Cash	198364675
CY2023Q4	us-gaap	Cash Cash	219125708
	fxe	Share Purchase And Redemptions Settlement Period Creation And Redemption SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption	P2D
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	fxe	Rule10 B51 Arr Modified Flag Rule10B51ArrModifiedFlag	false
CY2024Q3	fxe	Non Rule10 B51 Arr Modified Flag NonRule10B51ArrModifiedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000950170-24-122597-index-headers.html	Edgar Link	pending
0000950170-24-122597-index.html	Edgar Link	pending
0000950170-24-122597.txt	Edgar Link	pending
0000950170-24-122597-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fxe-20240930.htm	Edgar Link	pending
fxe-20240930.xsd	Edgar Link	pending
fxe-ex31_1.htm	Edgar Link	pending
fxe-ex31_2.htm	Edgar Link	pending
fxe-ex32_1.htm	Edgar Link	pending
fxe-ex32_2.htm	Edgar Link	pending
img174618080_0.jpg	Edgar Link	pending
img174618080_1.jpg	Edgar Link	pending
img174618080_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
fxe-20240930_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FXE
Invesco CurrencyShares Euro Trust Stock $fxe

2024 Q3 Form 10-Q Financial Statement

#000095017024122597 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FXE Invesco CurrencyShares Euro Trust Stock $fxe

2024 Q3 Form 10-Q Financial Statement

#000095017024122597 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FXE
Invesco CurrencyShares Euro Trust Stock $fxe